Skip to main content
SpringerLink
Log in

Magnesium in Psychoses

  • Chapter
New Perspectives in Magnesium Research

Abstract

Psychoses are severe psychiatric diseases. They affect a significant number of patients and have a various symptoms. The main psychoses are schizophrenia, major depression, and bipolar disorders. There are also other types of psychoses, such as interictal psychosis and postictal psychosis in epileptic patients.1 These psychoses were less studied regarding the infl uence on the changing concentrations of magnesium and other cations. Magnesium and other bivalent cations play multiple roles in the central nervous system (CNS). Misbalances in intra- or extracellular concentrations of these cations are met in some neurological and psychiatric diseases and are involved sometimes in the pathogenic mechanisms of these diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 269.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adachi N, Onuma T, Nishiwaki S, et al. Inter-ictal and post-ictal psychoses in frontal lobe epilepsy: a retrospective comparison with psychoses in temporal lobe epilepsy. Seizure 2000;9:328–335.

    Article  PubMed  CAS  Google Scholar 

  2. Frazer A, Ramsey TA, Swann A, et al. Plasma and erythrocyte electrolytes in affective disorders. J Affect Disord 1983;5:103–113.

    Article  PubMed  CAS  Google Scholar 

  3. Ramsey TA, Frazer A, Mendels J. Plasma and erythrocyte cations in affective illness. Neuropsychobiology 1979;5:1–10.

    PubMed  CAS  Google Scholar 

  4. George MS, Rosenstein D, Rubinow DR, Kling MA, Post RM. CSF magnesium in affective disorder: lack of correlation with clinical course of treatment. Psychiatry Res 1994;51:139–146.

    Article  PubMed  CAS  Google Scholar 

  5. Mick E, Biederman J, Faraone SV, Murray K, Wozniak J. Defining a developmental subtype of bipolar disorder in a sample of nonreferred adults by age at onset. J Child Adolesc Psychopharmacol 2003;13:453–462.

    Article  PubMed  Google Scholar 

  6. Schatzberg AF. Employing pharmacologic treatment of bipolar disorder to greatest effect. J Clin Psychiatry 2004;65(suppl. 15):15–20.

    PubMed  CAS  Google Scholar 

  7. Arban R, Maraia G, Brackenborough K, et al. Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania. Behav Brain Res 2005;158:123–132.

    Article  PubMed  CAS  Google Scholar 

  8. Avissar S, Schreiber G, Danon A, Belmaker RH. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 1988;331:440–442.

    Article  PubMed  CAS  Google Scholar 

  9. Amari L, Layden B, Nikolakopoulos J, et al. Competition between Li+ and Mg2+ in neuroblastoma SH-SY5Y cells: a fluorescence and 31P NMR study. Biophys J 1999;76:2934–2942.

    PubMed  CAS  Google Scholar 

  10. Gould TD, Quiroz JA, Singh J, Zarate CA, Manji HK. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Mol Psychiatry 2004;9:734–755.

    Article  PubMed  CAS  Google Scholar 

  11. Abukhdeir AM, Layden BT, Minadeo N, Bryant FB, Stubbs EB Jr, Mota de Freitas D. Effect of chronic Li+ treatment on free intracellular Mg2+ in human neuroblastoma SH-SY5Y cells. Bipolar Disord 2003;5:6–13.

    Article  PubMed  CAS  Google Scholar 

  12. Layden BT, Abukhdeir AM, Williams N, et al. Effects of Li(+) transport and Li(+) immobilization on Li(+)/Mg(2+) competition in cells: implications for bipolar disorder. Biochem Pharmacol 2003;66:1915–1924.

    Article  PubMed  CAS  Google Scholar 

  13. Thakar JH, Lapierre YD, Waters BG. Erythrocyte membrane sodium-potassium and magnesium ATPase in primary affective disorder. Biol Psychiatry 1985;20: 734–740.

    Article  PubMed  CAS  Google Scholar 

  14. Alexander DR, Deeb M, Bitar F, Antun F. Sodium-potassium, magnesium, and calcium ATPase activities in erythrocyte membranes from manic-depressive patients responding to lithium. Biol Psychiatry 1986;21:997–1007.

    Article  PubMed  CAS  Google Scholar 

  15. Layden B, Diven C, Minadeo N, Bryant FB, Mota de Freitas D. Li+/Mg2+ competition at therapeutic intracellular Li+ levels in human neuroblastoma SH-SY5Y cells. Bipolar Disord 2000;2:200–204.

    Article  PubMed  CAS  Google Scholar 

  16. Giannini AJ, Nakoneczie AM, Melemis SM, Ventresco J, Condon M. Magnesium oxide augmentation of verapamil maintenance therapy in mania. Psychiatry Res 2000;93:83–87.

    Article  PubMed  CAS  Google Scholar 

  17. Heiden A, Frey R, Presslich O, Blasbichler T, Smetana R, Kasper S. Treatment of severe mania with intravenous magnesium sulphate as a supplementary therapy. Psychiatry Res 1999;89:239–246.

    Article  PubMed  CAS  Google Scholar 

  18. Chouinard G, Beauclair L, Geiser R, Etienne P. A pilot study of magnesium aspartate hydrochloride (Magnesiocard) as a mood stabilizer for rapid cycling bipolar affective disorder patients. Prog Neuropsychopharmacol Biol Psychiatry 1990;14: 171–180.

    Article  PubMed  CAS  Google Scholar 

  19. Levine J, Panchalingam K, Rapoport A, Gershon S, McClure RJ, Pettegrew JW. Increased cerebrospinal fluid glutamine levels in depressed patients. Biol Psychiatry 2000;47:586–593.

    Article  PubMed  CAS  Google Scholar 

  20. Walden J, Grunze H, Olbrich H, Berger M. Importance of calcium ions and calcium antagonists in affective psychoses. Fortschr Neurol Psychiatr 1992;60:471–476.

    Article  PubMed  CAS  Google Scholar 

  21. Kirov GK, Tsachev KN., Magnesium, schizophrenia and manic-depressive disease. Neuropsychobiology 1990;23:79–81.

    PubMed  CAS  Google Scholar 

  22. Plenge P, Rafaelsen OJ. Lithium effects on calcium, magnesium and phosphate in man: effects on balance, bone mineral content, faecal and urinary excretion. Acta Psychiatr Scand 1982;66:361–373.

    PubMed  CAS  Google Scholar 

  23. Rybakowski J, Szajnerman Z. Lithium-magnesium relationship in red blood cells during lithium prophylaxis. Pharmakopsychiatr Neuropsychopharmakol 1976;9: 242–246.

    PubMed  CAS  Google Scholar 

  24. Nechifor M, Vaideanu C, Mindreci I, Palamaru I, Boisteanu P. Research on plasmatic and tissular concentration of some bivalent cations in patients with bipolar disorders. In: Ermidou Pollet S, Pollet S, eds. Abstract Book of 5th International Symposium on Trace Elements in Human: New Perspectives. Athens: Entypossis Athens Publishing House; 2005:18.

    Google Scholar 

  25. Bowden CL. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder. J Clin Psychiatry 2005;66(suppl. 3):12–19.

    PubMed  CAS  Google Scholar 

  26. Rybakowski J, Jankowiak E. Plasma and erythrocyte electrolytes in endogenous depression-neurophysiologic implications. Psychiatr Pol 1989;23:265–270.

    PubMed  CAS  Google Scholar 

  27. Banki CM, Vojnik M, Papp Z, Balla KZ, Arato M. Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol Psychiatry 1985;20:163–171.

    Article  PubMed  CAS  Google Scholar 

  28. Basarsky TA, Duffy SN, Andrew RD, MacVicar BA. Imaging spreading depression and associated intracellular calcium waves in brain slices. J Neurosci 1998;18: 7189–7199.

    PubMed  CAS  Google Scholar 

  29. Bowden CL, Huang LG, Javors MA, et al. Calcium function in affective disorders and healthy controls. Biol Psychiatry 1988;23:367–376.

    Article  PubMed  CAS  Google Scholar 

  30. Levine J, Stein D, Rapoport A, Kurtzman L. High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients. Neuropsychobiology 1999;39:63–70.

    Article  PubMed  CAS  Google Scholar 

  31. Widmer J, Stella N, Raffin Y, Bovier P, Gaillard JM, Hilleret H, Tissot R. Blood magnesium, potassium, sodium, calcium and cortisol in drug-free depressed patients. Magnes Res 1993;6:33–41.

    PubMed  CAS  Google Scholar 

  32. Kamei K, Tabata O, Muneoka K, Muraoka SI, Tomiyoshi R, Takigawa M. Electrolytes in erythrocytes of patients with depressive disorders. Psychiatry Clin Neurosci 1998;52:529–533.

    Article  PubMed  CAS  Google Scholar 

  33. Young LT, Robb JC, Levitt AJ, Cooke RG, Joffe RT. Serum Mg2+ and Ca2 /Mg2+ ratio in major depressive disorder. Neuropsychobiology 1996;34:26–28.

    Article  PubMed  CAS  Google Scholar 

  34. Nechifor M, Văideanu C, Boişteanu P, Mindreci I, Cuciureanu R, Nechifor C. Changes in Mg2+ and other cations plasmatic concentration in patients with major depression. In: Escanero JF, Alda JO, Guerra M, Durlach J, eds. Advances in Magnesium Research Physiology, Pathology and Pharmacology. Zaragoza: Prensas Universitarias de Zaragoza; 2003:177–181.

    Google Scholar 

  35. Singewald N, Sinner C, Hetzenauer A, Sartori SB, Murck H. Magnesium-deficient diet alters depression-and anxiety-related behavior in mice-influence of desipramine and Hypericum perforatum extract. Neuropharmacology 2004;47:1189–1197.

    PubMed  CAS  Google Scholar 

  36. Schlegel-Zawadzka M, Papp M, Krosniak M, Nowak G. Effect of chronic imipramine treatment on serum and plasma zinc levels in chronic mild stress model of depression in rats. In: Mengen und Spurenelemente. Leipzig: Verlag Harald Schubert; 1998:616–620.

    Google Scholar 

  37. Imada Y, Yoshioka S, Ueda T, Katayama S, Kuno Y, Kawahara R. Relationships between serum magnesium levels and clinical background factors in patients with mood disorders. Psychiatry Clin Neurosci 2002;56:509–514.

    Article  PubMed  CAS  Google Scholar 

  38. Lavoie PA, Beauchamp G, Elie R. Tricyclic antidepressants inhibit voltagedependent calcium channels and Na(+)-Ca2+ exchange in rat brain cortex synaptosomes. Can J Physiol Pharmacol 1990;68:1414–1418.

    PubMed  CAS  Google Scholar 

  39. Nechifor M. Involvement of some cations in major depression. In: Cser MA, Sziklai L, eds. Metal Ions in Biology and Medicine. Paris: John Libbey; 2004:518–521.

    Google Scholar 

  40. Jagadeesh SR, Subhash MN. Effect of antidepressants on intracellular Ca++ mobilization in human frontal cortex. Biol Psychiatry 1998;44:617–621.

    Article  PubMed  CAS  Google Scholar 

  41. Kanofsky JD, Sandyk R. Magnesium deficiency in chronic schizophrenia. Int J Neurosci 1991;61:87–90.

    Article  PubMed  CAS  Google Scholar 

  42. Athanassenas G, Papadopoulos E, Kourkoubas A, et al. Serum calcium and magnesium levels in chronic schizophrenics. J Clin Psychopharmacol 1983;3:212–216.

    Article  PubMed  CAS  Google Scholar 

  43. Yassa R, Nair NP, Schwartz G. Plasma magnesium in chronic schizo-phrenia. A preliminary report. Int Pharmacopsychiatry 1979;14:57–64.

    PubMed  CAS  Google Scholar 

  44. Nechifor M, Vaideanu C, Palamaru I, Borza C, Mindreci I. The influence of some antipsychotics on erythrocyte magnesium and plasma magnesium, calcium, copper and zinc in patients with paranoid schizophrenia. J Am Coll Nutr 2004;23:549S–551S.

    PubMed  CAS  Google Scholar 

  45. Jabotinsky-Rubin K, Durst R, Levitin LA, et al. Effects of haloperidol on human plasma magnesium. J Psychiatr Res 1993;27:155–159.

    Article  PubMed  CAS  Google Scholar 

  46. Kahn DA, Sachs GS, Printz DJ, Carpenter D, Docherty JP, Ross R. Medication treatment of bipolar disorder 2000: a summary of the expert consensus guidelines. J Psychiatr Pract 2000;6:197–211.

    Article  PubMed  CAS  Google Scholar 

  47. Nechifor M, Văideanu C, Mândeci I, Borza C. Variations of magnesium concentrations in psychoses. Magnes Res 2004;17:226.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, University of Medicine and Pharmacy “Gr. T. Popa”, Iasi, Romania

    Mihai Nechifor MD, PhD

Authors
  1. Mihai Nechifor MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan

    Yoshiki Nishizawa MD, PhD (Dean of Medicine, Professor of Internal Medicine) (Dean of Medicine, Professor of Internal Medicine)

  2. Osaka City University, Osaka, Japan

    Hirotoshi Morii MD, PhD (Emeritus Professor) (Emeritus Professor)

  3. Université Pierre et Marie Curie, Paris, France

    Jean Durlach MD, PhD (President of the International Society for the Development of Research on Magnesium (SDRM), Editor-in-Chief Magnesium Research journal) (President of the International Society for the Development of Research on Magnesium (SDRM), Editor-in-Chief Magnesium Research journal)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag London Limited

About this chapter

Cite this chapter

Nechifor, M. (2007). Magnesium in Psychoses. In: Nishizawa, Y., Morii, H., Durlach, J. (eds) New Perspectives in Magnesium Research. Springer, London. https://doi.org/10.1007/978-1-84628-483-0_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-483-0_30

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-388-8

  • Online ISBN: 978-1-84628-483-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation